Armstrong, April W. http://orcid.org/0000-0003-0064-8707
Jayade, Sayeli
Rege, Sanika http://orcid.org/0000-0002-2405-0147
Joshi, Namita
Patel, Vardhaman http://orcid.org/0000-0002-3636-3423
Kalirai, Samaneh
Wolin, Daniel http://orcid.org/0009-0004-4437-8424
Boyle, Kimberly
Patel, Dipen
Seigel, Lauren http://orcid.org/0000-0001-5977-3065
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 25 October 2023
Accepted: 13 December 2023
First Online: 22 January 2024
Declarations
:
: April W. Armstrong is a research investigator, scientific advisor, and/or speaker for AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Dermira, EPI, Incyte, Janssen, Leo, Lilly, Mindera Health, Nimbus, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharma, and UCB. April W. Armstrong was an employee of University of Southern California at the time of this study. She is currently an employee of the University of California Los Angeles, Los Angeles, CA, USA. Sayeli Jayade is an employee of OPEN Health, which received consulting fees from Bristol Myers Squibb in connection with this study. Sanika Rege, Dipen Patel, and Namita Joshi were employees of OPEN Health at the time of this study. Vardhaman Patel, Samaneh Kalirai, and Lauren Seigel are employees of Bristol Myers Squibb and may be shareholders in the company. Daniel Wolin and Kimberly Boyle are employees of RTI Health Solutions, which received consulting fees from Bristol Myers Squibb in connection with this study.
: The study protocol, survey, and relevant recruitment materials were evaluated by the RTI institutional review board and deemed exempt. This survey study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Participants who were deemed eligible after answering the survey’s screening questions were required to provide electronic consent via a checkbox.